HGH Fragment 176-191

Product Name: HGH Fragment 176–191
Synonyms: HGH Frag 176-191, Somatotropin Fragment 176-191
CAS Number: 221231-10-3
Molecular Formula: C78H123N23O23S2
Molecular Weight: ~1817.12 g/mol
Purity: ≥98% (HPLC Verified)
Form: Lyophilized Powder
Storage: Store lyophilized at -20°C; reconstituted solution should be kept at 2–8°C
Intended Use: For Laboratory Research Only – Not for Human Consumption

Product Overview

HGH Fragment 176-191 is a modified peptide fragment derived from the C-terminal end of the human growth hormone (hGH). It contains amino acid residues 176 through 191, representing less than 10% of the full hGH molecule. Despite this, studies suggest that HGH Frag 176-191 retains powerful lipolytic (fat-burning) properties without the undesired effects on insulin or IGF-1 levels associated with full-length HGH.

In various preclinical models, HGH Frag 176-191 has shown potential for enhancing fat metabolism, reducing adipose tissue, and preserving lean muscle mass, making it a subject of interest in obesity and metabolic research.

Mechanism of Action

Unlike full-length growth hormone, HGH Frag 176-191 is designed to selectively bind to adipose (fat) tissue receptors, stimulating lipolysis and inhibiting lipogenesis, especially in visceral fat depots.

Key Functional Highlights:

• Stimulates fat oxidation

• Reduces lipid accumulation

• Enhances energy expenditure

• Does not significantly impact glucose or IGF-1 levels

This selective action makes it a promising research candidate for metabolic regulation and weight management models.

Key Research Applications

🔥 Obesity & Fat Reduction Studies
Used in research focused on adipocyte metabolism, fat mass reduction, and visceral fat modulation.

💪 Muscle Preservation in Caloric Deficit
Investigated for potential to preserve lean mass while promoting fat loss in calorie-restricted or fasting models.

🧬 Endocrine & Metabolic Pathway Analysis
Valuable in studies assessing non-IGF mediated GH pathways, particularly in adipocyte-targeted research.

🩺 Preclinical Anti-Obesity Drug Development
Fragment 176-191 may assist in screening fat-targeted therapeutics with minimal endocrine disruption.

Suggested Reconstitution (Research Use Only)

• Solvent: Sterile Bacteriostatic Water (BAC) or Sodium Chloride (0.9%)

• Storage (Lyophilized): -20°C

• Storage (Reconstituted): Refrigerate at 2–8°C; use within 14–20 days

• Light Sensitive: Store in dark container post reconstitution

Always consult with your institution’s standard handling procedures before use.

Why Buy HGH Frag 176-191 from ChemDope.com?

• ✅ Ultra-High Purity Peptide (≥98%)

• ✅ GMP-Compliant Production & Lab Verified

• ✅ Includes CoA, SDS, & Full Batch Traceability

• ✅ Shipped in Discreet, Temperature-Safe Packaging

• ✅ Fast Global Shipping with Researcher-First Support

Disclaimer

HGH Fragment 176-191 is sold strictly for scientific research and in vitro use only. It is not intended for human consumption, medical, or veterinary applications. Purchasers must be verified professionals or institutions in compliance with local regulations.